Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coughlin Stoia Geller Rudman & Robbins LLP
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Sequenom, Inc.
May 24th, 2009
Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”) announced that a class action has been commenced in the United States District Court for the Southern District of California on behalf of purchasers of Sequenom, Inc. (“Sequenom”) (NASDAQ:SQNM) common stock during the period between June 4, 2008 and April 29, 2009 (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Darren Robbins of Coughlin Stoia at...
Source: Pharma Investments, Ventures & Law Weekly (2009-05-24)
|
